# Hopscotch Primary Care

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hopscotch-primary-care

- Industry: Healthcare
- Headquarters: Chicago, US
- Website: www.hellohopscotch.com/
- Total disclosed funding: $98M
- Latest round: Series D (Aug 18, 2026)
- Investors on record: 9

## About

Based in the US, Hopscotch Primary Care is a healthcare-based company that provides healthcare thorough health evaluation and screen for potential health issues to understand the customer's needs and develop a personalized care plan.
Founded in 2021 and based in the US, Hopscotch Primary Care is a healthcare-based company that provides healthcare thorough health evaluation and screen for potential health issues to understand the customer's needs and develop a personalized care plan. The company was founded by Kristin Myers (Peng) and Tim Gronniger serves as the CEO. In August 2026, Hopscotch Primary Care raised USD 53 million in series D funding co-led by 8VC and Townhall Ventures, with participation from a Moon, Citi Impact Fund, Alumni Ventures Group, K2 Health Ventures, Autism Impact Fund and Leon Levine Foundation.
The company provides a wide range of healthcare services such as primary care for seniors, Medicare-focused health management, personalized care plans, and support for Medicare Advantage and Medicare-Medicaid patients. Additionally, the firm also provides services such as building care teams, offering proactive care, and focusing on rural healthcare communities.
Hopscotch Primary Care generates revenue by providing value-based primary care services to Medicare and Medicare/Medicaid patients in rural communities. The company earns reimbursements through patient care services, chronic disease management, care coordination, and outcome-based incentive payments tied to improving health outcomes and reducing overall healthcare costs.
The company plans to use the August 2026 funding for the expansion into additional rural markets across the Southeastern United States, deepen healthcare access in underserved communities, and further scale its technology-enabled care platform and operations to improve patient outcomes and drive sustainable growth.

## Funding rounds

- Series D, Aug 18, 2026, $53M — Leon Levine Foundation, Alumni Ventures Group, 8VC, aMoon, Town Hall Ventures, K2 HealthVentures, Autism Impact Fund, Citi Impact Fund
- Series C, Jun 13, 2024, $45M — Alumni Ventures Group, 8VC, aMoon, Town Hall Ventures, K2 HealthVentures, CVS Health Ventures, Citi Impact Fund

## Investors

- Alumni Ventures Group (https://capitalatlas.ai/funds/alumni-ventures-group) — Series C, Series D
- 8VC (https://capitalatlas.ai/funds/8vc) — Series C, Series D
- aMoon (https://capitalatlas.ai/funds/amoon) — Series C, Series D
- Town Hall Ventures (https://capitalatlas.ai/funds/town-hall-ventures) — Series C, Series D
- K2 HealthVentures (https://capitalatlas.ai/funds/k2-healthventures) — Series C, Series D
- CVS Health Ventures (https://capitalatlas.ai/funds/cvs-health-ventures) — Series C
- Citi Impact Fund — Series C, Series D
- Leon Levine Foundation — Series D
- Autism Impact Fund (https://capitalatlas.ai/funds/autism-impact-fund) — Series D